Yohimbe Bark: The Stimulant That Sends People to the ER

← Back to articles

Yohimbe (Pausinystalia yohimbe) is an African tree whose bark contains yohimbine — a potent alpha-2 adrenergic antagonist. Prescription yohimbine exists as a historical erectile dysfunction drug; bulk bark extracts sold as libido, weight-loss, and pre-workout supplements are a different matter. The toxicity profile has earned yohimbe bark a permanent seat at the top of poison control call lists for botanical supplements.

Adverse Event Profile

A 2015 analysis of poison control calls in Drug Testing and Analysis reviewed 238 yohimbe-related cases. Severe adverse events included hypertensive crisis (systolic BP >180 mmHg), tachyarrhythmia (heart rate >140 bpm), syncope, seizures, and rhabdomyolysis. ICU admission occurred in roughly 10% of serious cases.

The Dose Problem

Yohimbine content in commercial yohimbe bark products varies from 0 to >100 mg per dose — sometimes without any indication on the label. A 2015 analysis of 49 yohimbe-containing supplements in Drug Testing and Analysis found labels frequently misrepresented actual yohimbine content, with some products containing 3–5 times the label claim. Consumers titrating dose based on labels have no reliable information.

Drug Interactions

Yohimbine interacts severely with MAOIs (risk of hypertensive crisis), SSRIs/SNRIs (risk of anxiety/panic, serotonin interactions), tricyclics, and other sympathomimetics (additive cardiac toxicity). It can destabilise blood pressure in hypertensive patients and precipitate panic attacks in anxiety-prone individuals.

Libido and Performance Claims

Prescription yohimbine at regulated doses (5.4 mg three times daily) has modest ED evidence. Bulk bark products aimed at libido or weight loss typically contain much higher doses in uncontrolled combinations with caffeine and other stimulants. The proposed alpha-2 antagonist fat-loss mechanism is real but clinically trivial in most users.

Who Should Absolutely Avoid

Anyone with cardiovascular disease, hypertension, anxiety or panic disorders, pregnancy, liver or kidney disease, bipolar disorder, or on psychiatric medications. Effectively, most of the population.

Bottom Line

If yohimbine is medically indicated, a prescription product at a defined dose under medical supervision is the only responsible route. Over-the-counter yohimbe bark products fail the most basic criteria of predictable dosing and acceptable risk-benefit and should be avoided.